Disc Medicine, Inc.
IRON
$58.97
-$0.79-1.32%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 12.18M | 9.75M | 8.17M | 7.37M | 7.76M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 39.95M | 34.55M | 32.86M | 30.85M | 31.46M |
| Operating Income | -39.95M | -34.55M | -32.86M | -30.85M | -31.46M |
| Income Before Tax | -33.97M | -29.28M | -26.49M | -26.29M | -26.94M |
| Income Tax Expenses | 119.00K | 176.00K | 114.00K | 60.00K | 5.00K |
| Earnings from Continuing Operations | -34.09M | -29.46M | -26.60M | -26.35M | -26.95M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -34.09M | -29.46M | -26.60M | -26.35M | -26.95M |
| EBIT | -39.95M | -34.55M | -32.86M | -30.85M | -31.46M |
| EBITDA | -39.93M | -34.54M | -32.85M | -30.74M | -31.44M |
| EPS Basic | -1.02 | -0.98 | -0.89 | -1.03 | -1.09 |
| Normalized Basic EPS | -0.64 | -0.61 | -0.55 | -0.64 | -0.68 |
| EPS Diluted | -1.02 | -0.98 | -0.89 | -1.03 | -1.09 |
| Normalized Diluted EPS | -0.64 | -0.61 | -0.55 | -0.64 | -0.68 |
| Average Basic Shares Outstanding | 33.32M | 30.00M | 29.94M | 25.65M | 24.81M |
| Average Diluted Shares Outstanding | 33.32M | 30.00M | 29.94M | 25.65M | 24.81M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |